2015 American Transplant Congress

May 2-6, 2015 in Philadelphia, Pennsylvania

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Calcineurin (CNI) Exposure Reduces the Risk of Post-Transplant DSA After Deceased Donor Kidney Transplantation

R. Pelletier, A. Rajab, G. Bumgardner, M. Henry.
Calcineurin Inhibitor-Free Immunossupresion After Kidney Transplantation, Using Everolimus De Novo – Single Center Experience

M. Stronka, Z. Adamska, L. Cichanska, J. Kubiak, M. Gamrat, M. Karczewski.
Calcineurin Inhibitors (CNI) Minimization Associated With Mammalian Target of Rapamycin Inhibitors (i-mTOR) to Improve Renal Function in Renal Grafts from Uncontrolled Donation After Cardiac Death Donors (UDCDD)

M. Molina,¹ E. Gutierrez,¹ S. González-Sanchidrian,² E. González,¹ J. Cabrera,¹ N. Polanco,¹ A. Hernández,¹ A. Sevillano,¹ M. Praga,¹ A. Andres.¹
Calcineurin-Inhibitor Conversion to mTOR Inhibitor in Renal Transplant Recipients Leads to Worse Long Term Clinical Outcomes

A. Alvarado,¹ A. Shetty,¹ O. Traitanon,¹ J. Leventhal,¹ V. Mas,² D. Chhabra,³ J. Matthews,¹ L. Gallon.¹
Campath Induction With Triple Maintenance Therapy in African American Kidney Transplant Recipients: Less Infections But Worse Graft Survival

M. Gillespie, F. Rasetto, B. Masters, T. Sparkes, B. Ravichandran, M. Moss, A. Haririan.
Can Gene-Expression Profiling Score Help Explain the Adverse Clinical Outcomes Seen in Gender-Mismatched Heart Transplants?

N. Sulemanjee,¹ P. Prasad,² T. Wolf,² V. Thohan,¹ J. Teuteberg.³
Can MitoQ Improve Renal and Mitochondrial Function Following Cold Storage and Transplantation?

L. MacMillan-Crow,¹ N. Parajuli,¹ D. Borja-Cacho.
Can Post-Transplant C-Peptide Be Used as an Indicator of Pancreas Graft Failure?

R. Carrico,¹ J. Fridell,² J. Odorico,³ R. Stratta,⁴ K. Tyler,¹ S. Niederhaus,⁵ R. Kandaswamy,⁶ J. Fisher,⁷ O. Olaitan,⁸ M. Mujtaba.²
Can the Need for Graft Nephrectomy After Late Renal Transplant Failure Be Predicted?

K. Bunthof, C. Verhoeks, L. Hilbrands.
Can We Use MDRD or CKD-EPI Equation for Donor Selection?

B. Moura, D. Machado, F. Agena, F. Paula, W. Nahas, E. David-Neto, F. Lemos.

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z